熱門資訊> 正文

Omeros 2025年第四季度盈利预览

2026-03-31 05:35

奧麥羅製藥(OMER) 0

Omeros (OMER) is scheduled to announce Q4 earnings results on Monday, March 30th, after market close.
The consensus EPS Estimate is $0.36 (+166.7% Y/Y) and the consensus Revenue Estimate is $0M
Over the last 1 year, OMER has beaten EPS estimates 75% of the time and has beaten revenue estimates 0% of the time.

More on Omeros

Omeros: Yartemlea Can Own The Label And Still Split The Market
Omeros Corporation (OMER) Discusses FDA Approval and Commercialization Plans for YARTEMLEA in TA-TMA Treatment Transcript
Omeros higher after first commercial sales of transplant therapy
Seeking Alpha’s Quant Rating on Omeros
Historical earnings data for Omeros

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。